Abstract:Chronic dysregulation of peripheral lipids has been found to be associated with depression and cognition, but their interaction has not been investigated. Growing evidence has highlighted the association between peripheral lipoprotein levels with depression and cognition with inconsistent results. We assessed the association between peripheral lipids, depression, and cognition while evaluating their potential interactions using robust clinically relevant predictors such as lipoprotein levels and chronic medical disorders that dysregulate lipoproteins. We report an association between peripheral lipids, depression, and cognition, suggesting a common underlying biological mechanism driven by lipid dysregulation in two independent studies. Analysis of a longitudinal study of a cohort at high or low familial risk for major depressive disorder (MDD) ( n = 526) found metabolic diseases, including diabetes, hypertension, and other cardiovascular diseases, were associated with MDD and cognitive outcomes. Investigating a cross-sectional population survey of adults in the National Health and Nutrition Examination Survey 2011–2014 (NHANES) ( n = 2377), depression was found to be associated with high density lipoprotein (HDL) and cognitive assessments. In the familial risk study, medical conditions were found to be associated with chronic lipid dysregulation and were significantly associated with MDD using the structural equation model. A positive association between chronic lipid dysregulation and cognitive scores was found in an exploratory analysis of the familial risk study. In a complementary study, analysis of NHANES revealed a positive association of HDL levels with cognition. Further analysis of the NHANES cohort indicated that depression status mediated the interaction between HDL levels and cognitive tests. Importantly, the protective effect of HDL on cognition was absent in those with depressive symptoms, which may ultimately result in worse outcomes leading to cognitive decline. These findings highlight the potential for the early predictive value of medical conditions with chronic lipid dyshomeostasis for the risk of depression and cognitive decline.

Neural correlates of the association between depression and high density lipoprotein cholesterol change

Association of Anhedonia with Brain-Derived Neurotrophic Factor and Interleukin-10 in Major Depressive Disorder

Association of non-HDL-C and depression: a cross-sectional analysis of the NHANES data

Abnormal Functional Connectivity Within the Prefrontal Cortex is Associated with Multiple Plasma Lipid Species in Major Depressive Disorder.

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Potential correlations between abnormal homogeneity of default mode network and personality or lipid level in major depressive disorder

The role of lipoprotein profile in depression and cognitive performance: a network analysis

Increased cognition connectivity network in major depression disorder: a FMRI study.

Dysregulated cerebral blood flow, rather than gray matter Volume, exhibits stronger correlations with blood inflammatory and lipid markers in depression

Elevated SCN11A Concentrations Associated with Lower Serum Lipid Levels in Patients with Major Depressive Disorder

Decreased inter-hemispheric cooperation in major depressive disorder and its association with neurotransmitter profiles

Serum Copper and Zinc Levels Correlate with Biochemical Metabolite Ratios in the Prefrontal Cortex and Lentiform Nucleus of Patients with Major Depressive Disorder

Network analysis of depressive symptoms and C-reactive protein levels in major depressive disorder

Correlations between alterations in global brain functional connectivity in patients with major depressive disorder and their genetic characteristics

Study of decreased serum levels of C1q/TNF-related protein 4 (CTRP4) in major depressive disorder

Lower cerebrovascular reactivity in prefrontal cortex and weaker negative functional connectivity between prefrontal cortex and insula contribute to white matter hyperintensity-related anxiety or depression

A Combination of Neuroimaging and Plasma Metabolomic Analysis Suggests Inflammation is Associated with White Matter Structural Connectivity in Major Depressive Disorder.

Altered brain connectivity with hippocampus in patients with major depressive disorder

Elevated VCAM-1 levels in peripheral blood are associated with brain structural and functional alterations in major depressive disorder

Depression and cognition are associated with lipid dysregulation in both a multigenerational study of depression and the National Health and Nutrition Examination Survey

Amygdala Connectivity Mediates the Association Between Anxiety and Depression in Patients with Major Depressive Disorder